Using imaging and RNA analysis to predict cancer recurrence in the head and neck
Combined Imaging and RNA Analyses to Predict Head and Neck Cancer Recurrence
This study is looking for ways to predict if head and neck cancers might come back after treatment by using special imaging and tests on your RNA, so we can tailor your care and improve your chances of staying cancer-free.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Washington University NIH-funded |
| Lab location | 1 site (Saint Louis, United States) |
| Project ID | NIH-10909477 on NIH RePORTER |
What this research studies
This research focuses on head and neck squamous cell carcinomas (HNSCCs), which are aggressive tumors that often recur after treatment. The study aims to develop methods for early prediction of cancer recurrence by combining advanced imaging techniques, such as PET and MRI, with RNA analysis to identify biomarkers associated with tumor behavior. By monitoring these biomarkers, the research seeks to improve personalized treatment strategies and enhance patient care. Patients will be evaluated through non-invasive imaging and RNA assessments to better understand their risk of recurrence.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with head and neck squamous cell carcinomas who are undergoing treatment.
Not a fit: Patients with non-squamous cell carcinomas or those who are not currently receiving treatment for head and neck cancer may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved prediction of cancer recurrence, allowing for more tailored and effective treatment plans for patients.
How similar studies have performed: Previous research has shown promise in using imaging and RNA biomarkers for cancer prediction, indicating that this approach may lead to significant advancements in patient care.
Where this research is happening
Saint Louis, United States
- Washington University — Saint Louis, United States (Active)
Researchers
- Principal investigator: Li, Hua — Washington University
- Study coordinator: Li, Hua
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.